prof. dr. Lars Vereecke
- ORCID iD
-
0000-0002-1593-862X
- Bio (via ORCID)
- My research lab is focusing on host-microbiota interactions in health and disease, using unique transgenic mouse models of human pathologies (IBD, arthritis, colorectal cancer). My research lab (host-microbiota interaction lab - HMI) is coördinating the germ-free and gnotobiotic mouse facility at Ghent University. I am teamleader at the VIB Center for Inflammation Research (IRC) and assistant professor at Ghent University.
Show
Sort by
-
New thoughts on the gut-immune axis of arthritis
-
- Journal Article
- A1
- open access
A guide to germ-free and gnotobiotic mouse technology to study health and disease
-
- Journal Article
- A1
- open access
Colibactin-driven colon cancer requires adhesin-mediated epithelial binding
-
- Journal Article
- A1
- open access
Metabolite-based inter-kingdom communication controls intestinal tissue recovery following chemotherapeutic injury
-
Neonatal microbiota colonization drives maturation of primary and secondary goblet cell mediated protection in the pre-weaning colon
-
- Journal Article
- A1
- open access
Myeloid A20 is critical for alternative macrophage polarization and type-2 immune-mediated helminth resistance
-
- Journal Article
- A1
- open access
Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice
-
- Journal Article
- A1
- open access
Integrated gut metabolome and microbiome fingerprinting reveals that dysbiosis precedes allergic inflammation in IgE-mediated pediatric cow's milk allergy
-
- Journal Article
- A1
- open access
The autoinflammation-associated NLRC4<SUP>V341A</SUP> mutation increases microbiota-independent IL-18 production but does not recapitulate human autoinflammatory symptoms in mice
-
- Journal Article
- A1
- open access
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1